Traction News and Research

RSS

Arrowhead decreases second-quarter consolidated operating expenses by 58%

Arrowhead Research Corporation today announced financial results for its fiscal 2010 second quarter ended March 31, 2010.

13 May 2010

Jubilant Organosys reports 17.7% increase in fourth-quarter consolidated revenue

Jubilant Organosys Limited, an integrated pharmaceutical industry player and the largest Custom Research and Manufacturing Services Company in India, today announced its financial results for Q4 & FY2010.

10 May 2010

DJOFL net sales increases 10.3% to $240.1 million for first-quarter 2010

DJO Incorporated a global provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced financial results for its operating subsidiary, DJO Finance LLC ("DJOFL"), for the first quarter of 2010, ended April 3, 2010.

6 May 2010

Genomic Health reports 22% revenue growth, 58% decrease in net loss for first-quarter 2010

Genomic Health, Inc. today reported financial results and business progress for the quarter ended March 31, 2010.

6 May 2010

Pay-for-performance may create unintended financial incentives for doctors to discriminate against obese patients

Pay-for-performance reimbursement models may create unintended financial incentives for doctors to discriminate against obese patients, measuring a patient's waist circumference may be more effective in predicting surgical outcomes than the more traditional body mass index measure, and childhood obesity doubles the risk of developing colon cancer, according to data being presented at Digestive Disease Week- 2010.

5 May 2010

AppDynamics closes Series B financing round, raises $11 million

AppDynamics, Inc.™, the next-generation Application Performance Management (APM) company, today announced that it has closed its Series B round of financing, and had raised $11 million. The round is co-led by existing Series A investors Lightspeed Venture Partners and Greylock Partners, and will support the company's continued expansion as it takes advantage of market demand for next-generation application performance management (APM). To date, the company has received $16.5 million in venture funding.

3 May 2010

Sexual addiction therapists Steffens Counseling and Hope Source Counseling form strategic partnership

Sexual addiction is defined as any sexually-related, compulsive behavior which interferes with normal living and causes severe stress on family, friends, loved ones, and one's work environment. Sex becomes the organizing principle of an addict's life to the extent they are willing to sacrifice what they cherish most in order to preserve and continue their unhealthy behavior.

26 Apr 2010

SGO white paper reviews current status of HPV typing, its benefits and deficiencies

The Society of Gynecologic Oncologists has published its second in a series of four papers on a variety of cervical cancer issues and topics that were the focus of its Forum "The Future Strategies for Cervical Cancer Prevention: What Do We Need to Do Now to Prepare."

22 Apr 2010

Federal health reform implementation stirring up state politics and policies

The Denver Post: In Colorado, Democratic Gov. Bill Ritter is scheduled to sign an executive order Tuesday that "health care advocates say is key to turning the federal government's vague framework for reform into reality." The order "will create a board of health-policy advisers to guide the transition to a new health system — everything from setting up a state insurance exchange to making sure the insurance commissioner has authority to guard against companies rejecting someone for being sick."

21 Apr 2010

NuVasive reports 36.3% increase in first-quarter 2010 revenue

NuVasive, Inc., a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today financial results for the quarter ended March 31, 2010.

21 Apr 2010

AstraZeneca/Targacept's TC-5214 for treatment resistant depression to earn Decision Resources' gold standard status

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for treatment resistant depression therapy, AstraZeneca/Targacept's TC-5214 will earn Decision Resources' proprietary clinical gold standard status in 2013 (following its approval that year) and through 2018.

20 Apr 2010

ThromboGenics microplasmin Phase III program for symptomatic focal VMA meets primary endpoint

ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announces that its first Phase III trial with microplasmin for the non-surgical treatment of eye disease has met its primary endpoint>Europe, is due to report in the third quarter of 2010.

20 Apr 2010

Brains on Bikes raises funds for brain cancer research and support

Anne Feeley, a 55-year-old mother and brain cancer survivor, began a 3,781-mile ride across the country today to raise money and awareness for brain cancer research and support.

12 Apr 2010

Kaiser Health News examines health innovations from developing countries

Kaiser Health News examines several health care innovations that started out in developing countries and were then brought to the U.S.

12 Apr 2010

Derma Sciences reports 69% increase in Advanced Wound Care sales for fourth-quarter 2009

Derma Sciences, Inc., a specialty medical device/pharmaceutical company focused on advanced wound care, reported financial and operating results today for the three months and fiscal year ended December 31, 2009.

1 Apr 2010

INADA introduces new Sogno DreamWave Spa Massage Chair

World-leading distributor of massage chairs INADA, announced today its new Sogno DreamWave Spa Massage Chair in partnership with European Touch, the leading manufacturer of whirlpool pedicure spas.

31 Mar 2010

Location Based Technologies receives order from Stephen Gould for medical equipment, asset tracking devices

Location Based Technologies, Inc., a leading-edge service provider of personal, pet, and asset location devices, today announced that they have received an order from Stephen Gould Corporation for specialized medical equipment and asset tracking devices that will be utilized by a Southern California medical company.

22 Mar 2010

Coastal Contacts' sales up 15% for first fiscal quarter 2010

Coastal Contacts Inc. today announced its financial results for the three months ended January 31, 2010.

17 Mar 2010

TSO3 reports net loss of $9.2M for fiscal 2009

TSO3 Inc. an innovator in sterilization technology for medical devices in healthcare settings using ozone, posted sales totalling $1.3 million for the fiscal year ended December 31, 2009, compared to $2.2 million one year earlier. During the year, the Company sold five of its first generation STERIZONE(R) sterilizers and accessories, whereas it sold 13 in the preceding fiscal year.